CALYPTE BIOMEDICAL CORP.Calypte Biomedical Corp • November 12th, 2002 • Laboratory analytical instruments
The within is to confirm our understanding and agreement wherein our Company agreed to pay, and has paid to Bi-Costal Consulting, Inc. (“Bi-Costal”), a finder’s fee of fifteen percent (15%) with respect to your efforts in arranging for the financing of the aggregate sum of $3,125,000 in 8% Convertible Notes.
SUBSCRIPTION AGREEMENTSubscription Agreement • November 12th, 2002 • Calypte Biomedical Corp • Laboratory analytical instruments • New York
You, together with other subscribers (each a “Subscriber”) hereby agree to purchase, and Calypte Biomedical Corporation, a Delaware corporation (the “Company”), hereby agrees to issue and to sell to the Subscriber, Shares of the Company’s $.001 par value common stock (the “Company Shares”) for the consideration as set forth on the signature page hereof (“Purchase Price”). (The Company Shares are sometimes referred to herein as the “Shares”, “Common Shares”, “Securities”, or “Common Stock”). Upon acceptance of this Agreement by the Subscriber, the Company shall issue and deliver the Shares against payment, by federal funds wire transfer, or bank, or certified check of the Purchase Price.
